|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 152.21 ZAR | -0.09% |
|
+2.09% | +30.33% |
| 07-20 | Aspen Pharmacare wins Canada approval for generic Ozempic after Novo patent expiry | RE |
| 07-20 | Aspen Pharmacare wins Canada approval for generic Ozempic injection | RE |
| Market Cap | 67.58B 4.18B 3.62B 3.38B 3.09B 5.83B 399B 5.92B 39.68B 15.57B 200B 15.7B 15.36B 665B | P/E 2026 * |
15.5x | P/E 2027 * | 13.1x |
|---|---|---|---|---|---|
| Enterprise Value | 80.46B 4.98B 4.31B 4.03B 3.68B 6.94B 475B 7.05B 47.24B 18.54B 238B 18.69B 18.29B 791B | EV / Sales 2026 * |
2.14x | EV / Sales 2027 * | 1.69x |
| Free-Float |
59.64% | Yield 2026 * |
1.75% | Yield 2027 * | 1.65% |
Last Transcript: Aspen Pharmacare Holdings Limited
| 1 day | -0.09% | ||
| 1 week | +2.09% | ||
| Current month | +2.09% | ||
| 1 month | +3.49% | ||
| 3 months | +3.79% | ||
| 6 months | +38.56% | ||
| Current year | +30.33% |
| 1 week | 145.9 |  | 153.56 |
| 1 month | 142.6 | | 158.55 |
| Current year | 104.38 | | 160.79 |
| 1 year | 90.7 | | 160.79 |
| 3 years | 90.7 | | 252.96 |
| 5 years | 90.7 | | 281.67 |
| 10 years | 64.07 | | 382.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Saad
CEO | Chief Executive Officer | 62 | 1996-12-31 |
Sean Capazorio
DFI | Director of Finance/CFO | 61 | 2008-12-31 |
| Chief Operating Officer | 63 | 1998-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Saad
BRD | Director/Board Member | 62 | 1998-12-31 |
| Director/Board Member | 65 | 1998-12-31 | |
Kuseni Dlamini
CHM | Chairman | 58 | 2015-12-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 9/27/23 | Free | Chief Operating Officer | 12,236 | 0.0027% | ||
| 9/27/23 | Free | Executive/Senior Manager | 11,728 | 0.0026% | ||
| 9/27/23 | Free | Founder | 10,558 | 0.0024% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.09% | +2.09% | +35.68% | -22.93% | 4.18B | |
| -0.03% | -2.32% | +22.53% | +68.67% | 49.03B | |
| -1.14% | +13.15% | +60.80% | +127.29% | 42.33B | |
| +0.27% | -0.37% | -1.22% | +15.93% | 12.43B | |
| +0.43% | -0.69% | +19.53% | +69.15% | 11.68B | |
| -0.67% | +0.39% | +31.23% | +141.20% | 9.12B | |
| +3.81% | +7.21% | +22.98% | +37.90% | 7.15B | |
| +1.62% | +1.47% | +41.67% | -12.77% | 7.09B | |
| -1.22% | +0.78% | +11.47% | +171.70% | 6.76B | |
| +0.03% | +8.29% | -24.59% | +28.71% | 5.95B | |
| Average | +0.35% | +2.60% | +22.01% | +62.48% | 15.57B | |
| Weighted average by Cap. | -0.08% | +3.67% | +30.29% | +80.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.62B 2.33B 2.02B 1.88B 1.72B 3.24B 222B 3.29B 22.09B 8.67B 111B 8.74B 8.55B 370B | 38.86B 2.4B 2.08B 1.95B 1.78B 3.35B 229B 3.4B 22.82B 8.95B 115B 9.03B 8.83B 382B |
| Net income | 4.8B 297M 257M 240M 220M 414M 28.31B 420M 2.82B 1.11B 14.16B 1.11B 1.09B 47.18B | 5B 309M 268M 250M 229M 431M 29.48B 437M 2.93B 1.15B 14.75B 1.16B 1.14B 49.12B |
| Net Debt | 12.88B 797M 690M 645M 589M 1.11B 75.99B 1.13B 7.56B 2.97B 38.02B 2.99B 2.93B 127B | -1.74B -107M -92.95M -86.88M -79.4M -150M -10.24B -152M -1.02B -400M -5.12B -403M -394M -17.06B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-07 | ZAR 152.21 | -0.09% | 1,248,880 |
| 26-08-06 | ZAR 152.35 | +3.09% | 1,301,229 |
| 26-08-05 | ZAR 147.78 | -0.09% | 549,573 |
| 26-08-04 | ZAR 147.92 | +0.82% | 1,107,536 |
| 26-08-03 | ZAR 146.71 | -1.60% | 958,670 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- APN Stock
Select your edition
All financial news and data tailored to specific country editions
